A. Behmel

1.2k total citations
18 papers, 960 citations indexed

About

A. Behmel is a scholar working on Oncology, Molecular Biology and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, A. Behmel has authored 18 papers receiving a total of 960 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Oncology, 5 papers in Molecular Biology and 5 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in A. Behmel's work include Neuroendocrine Tumor Research Advances (4 papers), Neuroblastoma Research and Treatments (4 papers) and Genomic variations and chromosomal abnormalities (4 papers). A. Behmel is often cited by papers focused on Neuroendocrine Tumor Research Advances (4 papers), Neuroblastoma Research and Treatments (4 papers) and Genomic variations and chromosomal abnormalities (4 papers). A. Behmel collaborates with scholars based in Austria, United Kingdom and Germany. A. Behmel's co-authors include Roswitha Pfragner, Bruce A.J. Ponder, M.A. Ferguson‐Smith, Nigel P. Carter, Alan Tunnacliffe, Magnus Nordenskjöld, Håkan Telenius, W Rosenkranz, Elisabeth Ingolić and Bruno Niederle and has published in prestigious journals such as International Journal of Cancer, Human Genetics and Genes Chromosomes and Cancer.

In The Last Decade

A. Behmel

18 papers receiving 947 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
A. Behmel Austria 12 527 449 301 177 145 18 960
D. Depétris France 23 447 0.8× 1.1k 2.4× 173 0.6× 117 0.7× 73 0.5× 44 1.5k
Rosann A. Farber United States 21 259 0.5× 708 1.6× 122 0.4× 189 1.1× 53 0.4× 53 1.2k
F. Apiou France 15 245 0.5× 517 1.2× 61 0.2× 144 0.8× 80 0.6× 31 835
J. Kunz Germany 12 265 0.5× 274 0.6× 148 0.5× 126 0.7× 44 0.3× 19 584
F. J. Rauscher United States 11 226 0.4× 1.4k 3.1× 60 0.2× 150 0.8× 21 0.1× 13 1.6k
Marilena D. Papaioannou Switzerland 16 408 0.8× 658 1.5× 88 0.3× 47 0.3× 25 0.2× 17 1.3k
Albert de la Chapelle Finland 10 465 0.9× 541 1.2× 70 0.2× 47 0.3× 53 0.4× 11 1.0k
R. Marzella Italy 15 267 0.5× 923 2.1× 207 0.7× 64 0.4× 25 0.2× 25 1.4k
Donncha S. Dunican United Kingdom 17 388 0.7× 1.6k 3.6× 148 0.5× 108 0.6× 39 0.3× 21 1.8k
J.C. Irminger Switzerland 12 224 0.4× 559 1.2× 19 0.1× 102 0.6× 58 0.4× 13 917

Countries citing papers authored by A. Behmel

Since Specialization
Citations

This map shows the geographic impact of A. Behmel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. Behmel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. Behmel more than expected).

Fields of papers citing papers by A. Behmel

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A. Behmel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. Behmel. The network helps show where A. Behmel may publish in the future.

Co-authorship network of co-authors of A. Behmel

This figure shows the co-authorship network connecting the top 25 collaborators of A. Behmel. A scholar is included among the top collaborators of A. Behmel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A. Behmel. A. Behmel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Ulz, Peter, Harald Höger, Oskar A. Haas, et al.. (2011). High‐resolution analysis of alterations in medullary thyroid carcinoma genomes. International Journal of Cancer. 131(2). E66–73. 18 indexed citations
2.
Pfragner, Roswitha, A. Behmel, Harald Höger, et al.. (2009). Establishment and characterization of three novel cell lines - P-STS, L-STS, H-STS - derived from a human metastatic midgut carcinoid.. PubMed. 29(6). 1951–61. 43 indexed citations
3.
Weinhäusel, Andreas, A. Behmel, Bruce A.J. Ponder, et al.. (2003). Long-Term Follow Up of a "Sporadic" Unilateral Pheochromocytoma Revealing Multiple Endocrine Neoplasia MEN2A-2 in an Elderly Woman. Endocrine Pathology. 14(4). 375–382. 5 indexed citations
4.
Behmel, A., et al.. (2001). Chronic myeloid leukemia with a rare variant Philadelphia translocation. Cancer Genetics and Cytogenetics. 129(1). 76–79. 10 indexed citations
5.
Pfragner, Roswitha, Reinhard Ullmann, A. Behmel, & Helmut Popper. (2001). Comparative genomic hybridization and cytogenetic analysis in a bronchial adenoma: Three clones with different chromosomal aberrations. International Journal of Oncology. 18(5). 923–8. 1 indexed citations
6.
Behmel, A., Traudl Henn, Gerhard Wirnsberger, et al.. (1999). Cytogenetic and CGH studies of four neuroendocrine tumors and tumor-derived cell lines of a patient with multiple endocrine neoplasia type 1.. International Journal of Oncology. 15(1). 41–51. 13 indexed citations
7.
Pfragner, Roswitha, A. Behmel, Dean P. Smith, et al.. (1998). First continuous human pheochromocytoma cell line: KNA Biological, cytogenetic and molecular characterization of KNA cells. Journal of Neurocytology. 27(3). 175–186. 17 indexed citations
8.
Pfragner, Roswitha, Gerhard Wirnsberger, Bruno Niederle, et al.. (1996). Establishment of a continuous cell line from a human carcinoid of the small intestine (KRJ-I). International Journal of Oncology. 8(3). 513–20. 49 indexed citations
9.
Eng, Charis, Lois M. Mulligan, Darrin P. Smith, et al.. (1995). Mutation of the RET protooncogene in sporadic medullary thyroid carcinoma. Genes Chromosomes and Cancer. 12(3). 209–212. 123 indexed citations
10.
Orth, Ulrike, Fiorella Gurrieri, A. Behmel, et al.. (1994). Gene for Simpson‐Golabi‐Behmel syndrome is linked to HPRT in Xq26 in two European families. American Journal of Medical Genetics. 50(4). 388–390. 17 indexed citations
11.
Pfragner, Roswitha, Gerhard Wirnsberger, A. Behmel, et al.. (1993). NEW CONTINUOUS CELL-LINE FROM HUMAN MEDULLARY-THYROID CARCINOMA - SINJ - PHENOTYPIC ANALYSIS AND INVIVO CARCINOGENESIS. International Journal of Oncology. 2(5). 831–6. 13 indexed citations
12.
Telenius, Håkan, Bruce A.J. Ponder, Alan Tunnacliffe, et al.. (1992). Cytogenetic analysis by chromosome painting using dop‐pcr amplified flow‐sorted chromosomes. Genes Chromosomes and Cancer. 4(3). 257–263. 467 indexed citations
13.
Pfragner, Roswitha, Gerhard Wirnsberger, A. Behmel, et al.. (1992). Biologic and cytogenetic characterization of three human medullary thyroid carcinomas in culture.. PubMed. 40(3-4). 299–302. 5 indexed citations
14.
Pfragner, Roswitha, et al.. (1990). Establishment and characterization of continuous cell line MTC-SK derived from a human medullary thyroid carcinoma.. PubMed. 50(13). 4160–6. 43 indexed citations
15.
Behmel, A., E Plöchl, & W Rosenkranz. (1988). A new X‐linked dysplasia gigantism syndrome: Follow up in the first family and report on a second Austrian family. American Journal of Medical Genetics. 30(1-2). 275–285. 34 indexed citations
16.
Behmel, A., et al.. (1984). A new X-linked dysplasia gigantism syndrome: Identical with the Simpson dysplasia syndrome?. Human Genetics. 67(4). 409–413. 96 indexed citations
17.
Müller, W, et al.. (1983). Lungenagenesie bei partieller Trisomie 2 p und 21 q. Klinische Pädiatrie. 195(4). 291–293. 4 indexed citations
18.
Behmel, A., et al.. (1980). [Clinical importance of chromosomal translocations (author's transl)].. PubMed. 92(11). 395–405. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026